Medicinal Chemistry



Kerwin, Sean M., Ph.D.
Professor of Med. Chem.
G.D. Searle & Co.
Endowed Fellowship in Pharmacy
BME 6.202C

Recent Publications

McKee, M. L., Kerwin, S. M. “Synthesis, Metal Ion Binding, and Biological Evaluation of New Anticancer 2-(2’-Hydroxyphenyl)benzoxazole Analogs of UK-1” Bioorg. Med. Chem. 2008, 16, 1775-1783.

Tuesuwan, B.; Kern, J. T.; Thomas, P. W.; Rodriguez, M. L.; Li, J.; David, W. M.; Kerwin, S. M “Simian Virus 40 Large T-antigen G-Quadruplex DNA Helicase Inhibition by G-Quadruplex DNA-Interactive Agents” Biochemistry 2008, 47, 1896-1909.

Laroche, C.; Li, J.; Freyer, M. S.; Kerwin, S. M. “Coupling Reactions of Bromoalkynes with Imidazoles Mediated by Copper Salts:  Synthesis of Novel N-Alkynylimidazoles” J. Org. Chem., 2008, 73, 6462-6465.

Mandal, S.; Li, W.-T.; Bai, Y.; Robertus, J. D.; Kerwin, S. M. “Synthesis of 2-Substituted 9-Oxa-guanines [5-Amino-oxazolo[5,4-d]pyrimidin-7(6H)-ones] and 9-Oxa-2-thio-xanthines [5-Mercapto-oxazolo[5,4-d]pyrimidin-7(6H)-ones]” Beilstein J. Org. Chem. 2008, 4(26), 1-5.

Marriner, W. A.; Kerwin, S. M. “An Improved Synthesis of N’-Nitroso-Nornicotine-5’-Acetate” J. Org. Chem. 200974,  2891-2892.

Laroche, C.; Li, J.; Kerwin, S. M. “Lithiation and Functionalization of N-Alkynylimidazoles at the 2-Position” Tetrahedron Lett. 2009, 50, 5194-5197.

Laroche, C.; Kerwin, S. M. “Efficient, Regioselective Access to Bicyclic Imidazo[1,2-x]- Heterocycles via Gold and Base Promoted Cyclization of 1-Alkynylimidazoles” J. Org. Chem. 2009, 74, 9229-9232.

Li, J.; Kaoud, T. S.; Laroche, C.; Dalby, K. N.; Kerwin, S. M. “Synthesis and Biological Evaluation of p53a Kinase-Targeting Dialkynylimidazoles.” Bioorg. Med. Chem. Lett.  2009, 19, 6293-6297.

Wang, X.; Stavchansky, S.; Kerwin, S. M.; Bowman, P. D. “Structure-activity Relationships in the Cytoprotective Effect of Caffeic Acid Phenethyl Ester (CAPE) and Fluorinated Derivatives: Effects on Heme Oxygenase-1 Induction and Antioxidant Activities. Eur. J. Pharmacol. 2010, 635, 16-22.

Laroche, C.; Li, J.; Golzales, C.; David, W. M.; Kerwin, S. M. “Cyclization Kinetics and Biological Evaluation of an Anticancer 1,2-Dialkynylimidazole” Org. Biomol. Chem. 2010, 8, 1535 – 1539.

Yang, J.; Marriner, G. A.; Wang, X.; Bowman, P. D.; Kerwin, S. M.; Stavchansky, S. “Synthesis of a Series of Caffeic Acid Phenethyl Amide (CAPE) Fluorinated Derivatives: Comparison of Cytoprotective Effects to Caffeic Acid Phenethyl Ester (CAPE)” Bioorg. Med. Chem. 2010, 18, 5032-5038.

Laroche, C.; Li, J.; Kerwin, S. M. “Cytotoxic 1,2-Dialkynylimidazole-Based Aza-Enediynes:  Aza-Bergman Rearrangement Rates do not Predict Cytotoxicity” J. Med. Chem. 2011, 54, 5059-5069.

Schoonover, M.; Kerwin, S. M. “G-Quadruplex DNA Cleavage Preference and Identification of a Perylene Diimide G-Quadruplex Photocleavage Agent Using a Rapid Fluorescent Assay” Bioorg. Med. Chem. 2012, 20, 6904–6918.

Li, J.; Kaoud, T. S.; LeVieux, J.; Gilbreath, B.; Moharana, S.; Dalby, K, N.; Kerwin, S. M. “A fluorescence-based assay for p38a docking site binders: Identification of the Hypoxis natural product rooperol as a novel p38a kinase inhibitor” ChemBioChem, 2012, in press.

More information about Dr. Kerwin
> Affiliations
> Return to Kerwin's Home Page
Last Reviewed: December 11, 2012

Division Information

Mailing Address:
The University of Texas
at Austin
Medicinal Chemistry
BME 6.202
College of Pharmacy
The University of Texas
at Austin
2409 University Ave.
Stop A1900
Austin, TX, USA

Email Address: pharmacy

Phone: 512-471-5263
Fax: 512-232-2606

College Mourns Creed Abell

Creed Wills Abell III, Ph.D., of Austin, died Tuesday, September 9, 2014.

Dr. Abell was internationally recognized for his contribution to neurochemistry and neurobiology. His work contributed to the scientific information and understanding regarding diseases such as Parkinson's and Alzheimer's and to the understanding of how aging affects neurological function.

>Read more.

index of the major headings: a b c d e f g h i j k l m n o p q r s t u v w x y z